Sunrui Chen

Rotterdam, ZH, Netherlands

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 12 publications

Letter to the Editor: High Mobility Group Box Protein 1 Release Is an Identified Driver of Inflammation in the Pathogenesis of Biliary Atresia.

Letter to the Editor: High Mobility Group Box Protein 1 Release Is an Identified Driver of Inflammation in the Pathogenesis of Biliary Atresia.

Journal: Hepatology (Baltimore, Md.)

Published: June 24, 2021

Rotavirus Infection and Cytopathogenesis in Human Biliary Organoids Potentially Recapitulate Biliary Atresia Development.

Rotavirus Infection and Cytopathogenesis in Human Biliary Organoids Potentially Recapitulate Biliary Atresia Development.

Journal: mBio

Published: August 27, 2020

Drug screening identifies gemcitabine inhibiting rotavirus through alteration of pyrimidine nucleotide synthesis pathway.

Drug screening identifies gemcitabine inhibiting rotavirus through alteration of pyrimidine nucleotide synthesis pathway.

Journal: Antiviral research

Published: March 27, 2020

Pregnane X receptor activation constrains mucosal NF-κB activity in active inflammatory bowel disease.

Pregnane X receptor activation constrains mucosal NF-κB activity in active inflammatory bowel disease.

Journal: PloS one

Published: May 24, 2019

The Eukaryotic Translation Initiation Factor 4F Complex Restricts Rotavirus Infection via Regulating the Expression of IRF1 and IRF7.

The Eukaryotic Translation Initiation Factor 4F Complex Restricts Rotavirus Infection via Regulating the Expression of IRF1 and IRF7.

Journal: International journal of molecular sciences

Published: March 11, 2019

Suppression of pyrimidine biosynthesis by targeting DHODH enzyme robustly inhibits rotavirus replication.

Suppression of pyrimidine biosynthesis by targeting DHODH enzyme robustly inhibits rotavirus replication.

Journal: Antiviral research

Published: December 07, 2018

Nitazoxanide Inhibits Human Norovirus Replication and Synergizes with Ribavirin by Activation of Cellular Antiviral Response.

Nitazoxanide Inhibits Human Norovirus Replication and Synergizes with Ribavirin by Activation of Cellular Antiviral Response.

Journal: Antimicrobial agents and chemotherapy

Published: April 09, 2018

IRF-1, RIG-I and MDA5 display potent antiviral activities against norovirus coordinately induced by different types of interferons.

IRF-1, RIG-I and MDA5 display potent antiviral activities against norovirus coordinately induced by different types of interferons.

Journal: Antiviral research

Published: January 21, 2018

6-Thioguanine inhibits rotavirus replication through suppression of Rac1 GDP/GTP cycling.

6-Thioguanine inhibits rotavirus replication through suppression of Rac1 GDP/GTP cycling.

Journal: Antiviral research

Published: December 17, 2017

TNF-α exerts potent anti-rotavirus effects via the activation of classical NF-κB pathway.

TNF-α exerts potent anti-rotavirus effects via the activation of classical NF-κB pathway.

Journal: Virus research

Published: November 17, 2017

Basal interferon signaling and therapeutic use of interferons in controlling rotavirus infection in human intestinal cells and organoids.

Basal interferon signaling and therapeutic use of interferons in controlling rotavirus infection in human intestinal cells and organoids.

Journal: Scientific reports

Published: September 14, 2017

PI3K-Akt-mTOR axis sustains rotavirus infection via the 4E-BP1 mediated autophagy pathway and represents an antiviral target.

PI3K-Akt-mTOR axis sustains rotavirus infection via the 4E-BP1 mediated autophagy pathway and represents an antiviral target.

Journal: Virulence

Published: May 06, 2017

Showing 1-12 of 12

Last Updated: 09/26/2026